1
|
Pain perception is altered by a nucleotide polymorphism in SCN9A.
|
Proc Natl Acad Sci U S A
|
2010
|
1.79
|
2
|
NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders.
|
J Neurosci
|
2008
|
1.70
|
3
|
A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease.
|
J Crohns Colitis
|
2011
|
1.54
|
4
|
Over-expression of COX-2 mRNA in colorectal cancer.
|
BMC Gastroenterol
|
2014
|
1.06
|
5
|
Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia.
|
Brain
|
2010
|
1.04
|
6
|
High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk.
|
Int J Oncol
|
2012
|
0.95
|
7
|
COX-2 polymorphisms and the risk for head and neck cancer in white patients.
|
Head Neck
|
2009
|
0.95
|
8
|
Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease.
|
Gastroenterology
|
2004
|
0.93
|
9
|
Primary erythermalgia as a sodium channelopathy: screening for SCN9A mutations: exclusion of a causal role of SCN10A and SCN11A.
|
Arch Dermatol
|
2008
|
0.84
|
10
|
EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians.
|
Oncol Rep
|
2012
|
0.83
|
11
|
Microsomal epoxide hydrolase genotypes and the risk for head and neck cancer.
|
Head Neck
|
2008
|
0.83
|
12
|
Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer.
|
Int J Cancer
|
2010
|
0.80
|
13
|
Autosomal dominant polycystic liver disease in a family without polycystic kidney disease associated with a novel missense protein kinase C substrate 80K-H mutation.
|
World J Gastroenterol
|
2005
|
0.78
|
14
|
No role for glutathione S-transferase genotypes in Caucasian esophageal squamous cell or adenocarcinoma etiology: an European case-control study.
|
BMC Gastroenterol
|
2013
|
0.78
|
15
|
The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
|
Thromb Haemost
|
2008
|
0.77
|